Biodesix, Inc. BDSX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s EPS (diluted)?
- Biodesix, Inc. (BDSX) reported EPS (diluted) of -$0.81 in Q1 2026.
- How has Biodesix, Inc.'s EPS (diluted) changed year-over-year?
- Biodesix, Inc.'s EPS (diluted) increased by 46.7% year-over-year, from -$1.52 to -$0.81.
- What is the long-term trend for Biodesix, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Biodesix, Inc.'s EPS (diluted) has grown at a 16.7% compound annual growth rate (CAGR), from -$1.72 to -$3.19.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.